The global genomics market is expanding rapidly due to factors like personalized treatment, gene therapy, and rising cancer rates. The pharmaceutical sector dominated in 2023, with North America leading. Gene editing and cell therapies are growing, with Regeneron Pharmaceuticals showing promising growth potential and innovative treatments.